Skip to main content
Home

Main navigation

  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes
  • About GHWP
    • Vision, Mission and Goals
    • Terms of Reference
    • House Rules
    • Organization Structure
    • Strategic Framework
    • Legal Entity (ASL)
    • Liaison Members of GHWP
    • Activities
    • GHWP Playbook
  • Members
    • Brunei Darussalam
    • Cambodia
    • Chile
    • Chinese Taipei
    • Cuba
    • Egypt
    • Hong Kong SAR, China
    • India
    • Indonesia
    • Japan
    • Jordan
    • Kazakhstan
    • Kingdom of Bahrain
    • Kingdom of Saudi Arabia
    • Kyrgyz Republic
    • Laos PDR
    • Malaysia
    • Mongolia
    • Myanmar
    • Pakistan
    • People's Republic of China
    • Philippines
    • Republic of Kenya
    • Republic of Korea
    • Singapore
    • South Africa
    • State of Kuwait
    • Sultanate of Oman
    • Tanzania
    • Thailand
    • United Arab Emirates
    • Vietnam
    • Yemen
    • Zimbabwe
  • Technical committee
    • Work Group 1 (WG1) - Pre-Market Submission and CSDT
    • Work Group 2 (WG2) - Pre-market: IVDD
    • Work Group 3 (WG3) - Pre-market: Software as a Medical Device
    • Work Group 4 (WG4) - Post-Market
    • Work Group 5 (WG5) - Clinical Evidence for Performance and Safety
    • Work Group 7 (WG7) - Quality Management System
    • Work Group 8 (WG8) - Standards
    • Work Group 9 (WG9) - UDI & Nomenclature
    • Special Task Group-Common Evaluation Reliance Practice (CERP)
    • Terms of Reference
    • Work Plan and Target
  • GHWP Academy
    • GHWP (Guangzhou) Academy
  • News
  • Events Announcements
    • Event Sponsors
  • Events
    • Photo & Video Gallery
    • Presentations
  • Country/Region Updates
  • Documents
    • Minutes
    • Reports
    • Final Documents
    • Guidance Documents
    • Reference Document
    • Forms
    • Others
  • SADS Online
  • Trade Related Issue
  • Web Resources
  • Secretariat
  • Archive
    • Background & Objectives
    • GHWP Minutes
    • TC Minutes

Log on Here

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.
Get new captcha!
  • Reset your password
Submitted by admin on Thu, 10/06/2016 - 14:31

Work Group 2 (WG2) - Post-Market Surveillance and Vigilance

Powered by Drupal. Designed by Access-2-Healthcare.

2022 All rights reserved

Footer

  • Home
  • About us
  • Contact
  • Disclaimer
  • Terms of Use
  • Home
  • Chairman's Message
  • Historical Development
  • Meeting Calendar
  • Contact